If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

PDMR Announcement

12 Nov 2020 07:00

RNS Number : 0495F
K3 Business Technology Group PLC
12 November 2020
 

AIM: KBT

 

K3 Business Technology Group plc

("K3", "Company" or "Group")

PDMR Announcement

K3 Business Technology Group plc received notification on 10 November 2020 from Kestrel Partners LLP ("Kestrel") that on 10 November 2020 it acquired, on behalf of its discretionary clients, 68,000 ordinary shares of 25p each ("Shares") in the Company at a price of £1.147794 per share. In addition, on the 03 November 2020, Kestrel transferred in the market 39,740 ordinary shares at a price of £0.96 per share between accounts held by its discretionary clients. The notification also included the matters set out below.

Mr Scott, a non-executive director of K3, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in K3 Business Technology Group plc.

Following these transactions, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 7,895,241 Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest hold 2,525,950 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 10,421,191 Shares in the Company, which represents 24.27% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

7,893,741

18.38%

Indirect

JIM Nominees Limited

415,981

0.97%

Indirect

Bank of New York Nominees Ltd

2,071,659

4.83%

Indirect

Bank of New York Nominees Ltd

36,810

0.09%

 

For further information contact:

K3 Business Technology Group plc

+44 (0) 161 876 4498

Adalsteinn Valdimarsson, CEO

 

Rob Price, CFO

 

 

 

finnCap Ltd

+44 (0) 207 220 0500

Nominated Adviser and Broker

 

Julian Blunt/James Thompson (Corporate finance)

 

Richard Chambers (Corporate Broking)

 

 

 

 

 

 

 

 

 

    

 

 

 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP ('Kestrel')

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of K3 Business Technology Group plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

K3 Business Technology Group plc

b)

 

LEI

 

 

213800QOJ9OF2AV81748

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

25p Ordinary Shares

 

 

 

ISIN: GB00B00P6061

 

b)

 

Nature of the transaction

 

 

Purchase and Transfer 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

£1.147794

 

68,000 Shares - Purchase

 

£0.95

 

39,740 Shares -

Transfer

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Total 68,000 Shares @ £1.147794.

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

03/11/2020 - Transfer

10/11/2020 - Purchase

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBIBDBLXBDGGB
Date   Source Headline
29th Nov 20215:36 pmRNSDirector/PDMR Shareholding
22nd Nov 20214:43 pmRNSPDMR Announcement
15th Nov 20212:30 pmRNSDirector/PDMR Shareholding
10th Nov 20215:06 pmRNSPDMR Announcement
18th Oct 202112:48 pmRNSPDMR Announcement
4th Oct 20213:00 pmRNSPDMR Announcement
27th Sep 20212:03 pmRNSPDMR Announcement
22nd Sep 202111:02 amRNSPDMR Announcement
20th Sep 20217:00 amRNSSale of Sage Business for £1.68m cash
26th Jul 20217:00 amRNSInterim Results
1st Jul 202111:37 amRNSHolding(s) in Company
21st Jun 20214:00 pmRNSPDMR Announcement
18th Jun 20214:54 pmRNSMarket Price Share Option Scheme
14th Jun 20218:08 amRNSPDMR Announcement
2nd Jun 202111:45 amRNSHolding(s) in Company
1st Jun 202110:46 amRNSPDMR Announcement
19th May 20211:30 pmRNSResult of AGM
12th May 20215:57 pmRNSDirector/PDMR Share Purchase
5th May 20211:43 pmRNSPDMR Announcement
4th May 20212:52 pmRNSDirector/PDMR Share Purchase
23rd Apr 20217:00 amRNSNotice of AGM and Posting of Annual Report
9th Apr 20212:49 pmRNSHolding(s) in Company
9th Apr 20212:47 pmRNSHolding(s) in Company
9th Apr 20212:46 pmRNSHolding(s) in Company
6th Apr 20214:59 pmRNSPDMR Announcement
30th Mar 20217:30 amRNSLong Term Incentive Plan Option Scheme
30th Mar 20217:30 amRNSShareholder Loan Conversion
30th Mar 20217:00 amRNSFinal Results
30th Mar 20217:00 amRNSAppointment of Chief Executive Officer
5th Mar 20217:00 amRNSBoard Change
1st Mar 20213:54 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSSale of subsidiary
13th Nov 20207:00 amRNSLong Term Incentive Plan
12th Nov 20207:00 amRNSPDMR Announcement
2nd Nov 20207:00 amRNSTrading Update
28th Oct 20207:00 amRNSAppointment of Chairman
28th Aug 202011:05 amRNSResult of General Meeting
12th Aug 20207:57 amRNSPDMR Announcement
11th Aug 20204:41 pmRNSSecond Price Monitoring Extn
11th Aug 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20204:03 pmRNSPDMR Announcement
4th Aug 20207:00 amRNSInterim Results
29th Jul 20205:25 pmRNSNotice of General Meeting & Posting Annual Report
27th Jul 20207:00 amRNSFinal Results
15th Jul 20203:15 pmRNSNotice of Results
22nd Jun 20207:00 amRNSNotice of Results
29th May 202012:11 pmRNSResult of AGM
29th May 20207:00 amRNSAGM and Notice of Results
5th May 20209:47 amRNSNotice of AGM
3rd Apr 20205:08 pmRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.